ZIMMER BIOMET HOLDINGS, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $252.40M.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $252.30M, a 8.80% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $252.40M, a 334.42% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for fiscal 2025 was $484.30M, a 42.67% decline from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for fiscal 2024 was $844.80M, a 20.96% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for fiscal 2023 was $698.40M, a 365.60% increase from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. treasury stock, value, acquired, cost method for fiscal 2022 was $150.00M.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $252.40M 10-Q · filed 2026-08-05 | $757.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $252.30M 10-Q · filed 2026-05-01 | $504.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $252.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $484.30M 10-K · filed 2026-02-20 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $290.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $893.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $231.90M 10-Q · filed 2026-05-01 | $988.70M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $58.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $844.80M 10-K · filed 2025-02-25 |
| 2024-09-30 | $603.30M 10-Q · filed 2025-11-05 | $1.23B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $95.40M 10-Q · filed 2025-08-07 | $623.50M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $88.00M 10-Q · filed 2025-05-05 | $542.40M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $440.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $698.40M 10-K · filed 2026-02-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | |
| 2023-06-30 | $14.30M 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $244.00M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $150.00M 10-K · filed 2025-02-25 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $415.50M 10-K · filed 2019-02-26 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | |
| 2016-03-31 | $415.50M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $150.00M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $400.50M 10-K · filed 2017-03-01 | |
| 2014-03-31 | $400.50M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $719.00M 10-K · filed 2016-02-29 | |
| 2013-03-31 | $392.00M 10-Q · filed 2013-05-08 | $736.00M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $139.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $485.60M 10-K · filed 2015-02-23 |
| 2012-09-30 | $97.60M 10-Q · filed 2012-11-06 | $489.20M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $106.50M 10-Q · filed 2012-08-07 | $940.90M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $141.60M 10-Q · filed 2012-05-03 | $955.50M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $143.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.05B 10-K · filed 2014-02-28 |
| 2011-09-30 | $549.30M 10-Q · filed 2011-11-02 | $1.01B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $121.10M 10-Q · filed 2011-08-08 | $683.90M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $236.10M 10-Q · filed 2011-05-05 | $648.20M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $101.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $505.60M 10-K · filed 2013-02-27 |
| 2010-09-30 | $225.70M 10-Q · filed 2010-11-03 | |
| 2010-06-30 | $85.40M 10-Q · filed 2010-08-05 | |
| 2009-12-31 | $1.33B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $923.70M 10-K · filed 2012-02-27 |
| 2009-09-30 | -$66.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-04 | |
| 2008-12-31 | -$737.00M 10-K · filed 2011-02-25 | |
| 2007-12-31 | -$576.30M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |